Click for best price
Irritable Bowel Syndrome with Diarrhea IBSD Drugs Market Size, Share 2023
| Market size in 2022 |
US$ 1428.3 million
|
Forecast Market size by 2029 |
US$ 2826.1 million
|
| Growth Rate |
CAGR of 10.2% |
Number of Pages |
79 Pages |
Irritable bowel syndrome (IBS) is a common disorder that affects the large intestine. Signs and symptoms include cramping, abdominal pain, bloating, gas, and diarrhea or constipation, or both. IBS is a chronic condition that need to manage long term.
IBS that causes increased diarrhea is often called IBS-D. Diarrhea predominant irritable bowel syndrome (IBS-D) is a subtype of IBS in which a person experiences frequent episodes of diarrhea with accompanying abdominal pain. Like IBS, IBS-D is a functional gastrointestinal disorder (FGD) in that there is no visible disease, inflammation, or injury to account for its symptoms. It is estimated that approximately a third of people who have IBS experience the disorder with diarrhea as the predominant bowel habit.
In this report, we study the drugs for diarrhea predominant irritable bowel syndrome (IBS-D).
This report aims to provide a comprehensive presentation of the global market for Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs. This report contains market size and forecasts of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in global, including the following market information:
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs companies in 2022 (%)
The global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market was valued at US$ 1428.3 million in 2022 and is projected to reach US$ 2826.1 million by 2029, at a CAGR of 10.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is the largest consumption place of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs, followed by Europe. The two account for more than 80% of the consumer market in together. The most used IBS-D drug is XIFAXAN, accounting for more than 60% of the market share, followed by Viberzi and Lotronex. IBS-D drugs are widely sold through hospital pharmacies and retail pharmacies.
We surveyed the Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segment Percentages, by Type, 2022 (%)
XIFAXAN
Viberzi
Lotronex
Other
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market, by Sales Channel, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segment Percentages, by Sales Channel, 2022 (%)
Hospitals Pharmacy
Retail Pharmacy
Other
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs revenues share in global market, 2022 (%)
Key companies Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bausch Health
Allergan
Sebela Pharmaceuticals
Astellas Pharmaceuticals
Amneal Pharms
Pharscin Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs, market overview.
Chapter 2: Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by sales channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 1428.3 million
|
| Forecast Market size by 2029 |
US$ 2826.1 million
|
| Growth Rate |
CAGR of 10.2% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
79 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Sales Channel
1.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Overall Market Size
2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size: 2022 VS 2029
2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players in Global Market
3.2 Top Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Companies Ranked by Revenue
3.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Companies
3.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Companies
3.5 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players in Global Market
3.8.1 List of Global Tier 1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Markets, 2022 & 2029
4.1.2 XIFAXAN
4.1.3 Viberzi
4.1.4 Lotronex
4.1.5 Other
4.2 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue & Forecasts
4.2.1 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2018-2023
4.2.2 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2024-2029
4.2.3 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales & Forecasts
4.3.1 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2018-2023
4.3.2 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2024-2029
4.3.3 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Sales Channel
5.1 Overview
5.1.1 By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2022 & 2029
5.1.2 Hospitals Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue & Forecasts
5.2.1 By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2018-2023
5.2.2 By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2024-2029
5.2.3 By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2018-2029
5.3 By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales & Forecasts
5.3.1 By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2018-2023
5.3.2 By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2024-2029
5.3.3 By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2018-2029
5.4 By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2022 & 2029
6.2 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue & Forecasts
6.2.1 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2018-2023
6.2.2 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2024-2029
6.2.3 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales & Forecasts
6.3.1 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2018-2023
6.3.2 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2024-2029
6.3.3 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2018-2029
6.4.2 By Country - North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2018-2029
6.4.3 US Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.4.4 Canada Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.4.5 Mexico Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2018-2029
6.5.3 Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.5.4 France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.5.5 U.K. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.5.6 Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.5.7 Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.5.9 Benelux Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2018-2029
6.6.3 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.6.4 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.6.5 South Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.6.7 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2018-2029
6.7.2 By Country - South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2018-2029
6.7.3 Brazil Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.7.4 Argentina Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2018-2029
6.8.3 Turkey Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.8.4 Israel Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.8.6 UAE Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Bausch Health
7.1.1 Bausch Health Company Summary
7.1.2 Bausch Health Business Overview
7.1.3 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Product Offerings
7.1.4 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Bausch Health Key News & Latest Developments
7.2 Allergan
7.2.1 Allergan Company Summary
7.2.2 Allergan Business Overview
7.2.3 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Product Offerings
7.2.4 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Allergan Key News & Latest Developments
7.3 Sebela Pharmaceuticals
7.3.1 Sebela Pharmaceuticals Company Summary
7.3.2 Sebela Pharmaceuticals Business Overview
7.3.3 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Product Offerings
7.3.4 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Sebela Pharmaceuticals Key News & Latest Developments
7.4 Astellas Pharmaceuticals
7.4.1 Astellas Pharmaceuticals Company Summary
7.4.2 Astellas Pharmaceuticals Business Overview
7.4.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Product Offerings
7.4.4 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Astellas Pharmaceuticals Key News & Latest Developments
7.5 Amneal Pharms
7.5.1 Amneal Pharms Company Summary
7.5.2 Amneal Pharms Business Overview
7.5.3 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Product Offerings
7.5.4 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Amneal Pharms Key News & Latest Developments
7.6 Pharscin Pharma
7.6.1 Pharscin Pharma Company Summary
7.6.2 Pharscin Pharma Business Overview
7.6.3 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Product Offerings
7.6.4 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Pharscin Pharma Key News & Latest Developments
8 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Analysis
8.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, 2018-2029
8.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Supply Chain Analysis
10.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industry Value Chain
10.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Upstream Market
10.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in Global Market
Table 2. Top Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type
Table 9. List of Global Tier 1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), 2024-2029
Table 16. By Sales Channel ? Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), 2018-2023
Table 20. By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), 2024-2029
Table 21. By Region ? Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, (K Units), 2024-2029
Table 46. Bausch Health Company Summary
Table 47. Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offerings
Table 48. Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Bausch Health Key News & Latest Developments
Table 50. Allergan Company Summary
Table 51. Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offerings
Table 52. Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Allergan Key News & Latest Developments
Table 54. Sebela Pharmaceuticals Company Summary
Table 55. Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offerings
Table 56. Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Sebela Pharmaceuticals Key News & Latest Developments
Table 58. Astellas Pharmaceuticals Company Summary
Table 59. Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offerings
Table 60. Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Astellas Pharmaceuticals Key News & Latest Developments
Table 62. Amneal Pharms Company Summary
Table 63. Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offerings
Table 64. Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Amneal Pharms Key News & Latest Developments
Table 66. Pharscin Pharma Company Summary
Table 67. Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offerings
Table 68. Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Pharscin Pharma Key News & Latest Developments
Table 70. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 71. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 72. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production by Region, 2018-2023 (K Units)
Table 73. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production by Region, 2024-2029 (K Units)
Table 74. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Opportunities & Trends in Global Market
Table 75. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Drivers in Global Market
Table 76. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Restraints in Global Market
Table 77. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Raw Materials
Table 78. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Raw Materials Suppliers in Global Market
Table 79. Typical Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Downstream
Table 80. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Downstream Clients in Global Market
Table 81. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segment by Type in 2022
Figure 2. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segment by Sales Channel in 2022
Figure 3. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue in 2022
Figure 9. By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (USD/Unit), 2018-2029
Figure 13. By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2018-2029
Figure 15. By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2018-2029
Figure 16. By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2018-2029
Figure 23. US Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2018-2029
Figure 28. Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2018-2029
Figure 37. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Region, 2022 VS 2029
Figure 54. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industry Value Chain
Figure 55. Marketing Channels
